The Office of HIV/AIDS Network Coordination (HANC) works with the HIV/AIDS Clinical Trials Networks of the U.S. National Institutes of Health (NIH) with the intent of creating a more integrated, collaborative and flexible research structure. The networks are an affiliated group of national and international medical research institutions and investigators that conduct clinical HIV/AIDS research to develop safe and effective drugs, prevention strategies, and vaccines.
The Office of HIV/AIDS Network Coordination (HANC) is currently hiring for two positions:
Part-Time Project Coordinator: The Legacy Project
HANC is seeking a part-time (50%) Project Coordinator to join our team! View more details about this position and apply on the Fred Hutch Careers page.
Full-Time Project Manager: Cross-Network Coordination
HANC is seeking a Project Manager to join our team! View more details about this position and apply on the Fred Hutch Careers page.
SEATTLE (Wednesday, January 18, 2023) – A Phase 3 study of an investigational HIV vaccine regimen has been discontinued following a planned, interim review by the study’s independent Data and Safety Monitoring Board (DSMB) on Jan. 12, 2023.
The Mosaico study – also known as HPX3002/HVTN706 – a Phase 3 study conducted by the HIV Vaccine Trials Network (HVTN), based at Fred Hutchinson Cancer Center in Seattle, with a consortium of global partners. The study aimed to test a “mosaic”-based HIV vaccine in multiple countries around the world among cisgender men and transgender people who have sex with cisgender men and/or transgender people.
HVTN researchers and ethicists say findings will help guide new approaches to HIV vaccine studies
Read the full press release here.
The Office of HIV/AIDS Network Coordination (HANC) programs are referred to as areas of coordination. Within each area of coordination are numerous work groups that are integral to advancing the research goals and objectives defined by the HIV/AIDS Clinical Trials Networks and the Division of AIDS.
HANC supports a number of trans-institute behavioral science groups composed of experts that are working to advance research and clinical trials through cross-network collaboration.
HANC supports Community Partners, The Legacy Project, and the COVID-19 CAB coalition to achieve representation and build relationships with historically underrepresented communities in clinical research.
HANC supports cross-network working groups for network leadership, communications, data management centers, performance evaluation, and site coordinators to promote greater information sharing, collaboration, and process standardization.
HANC supports several cross-network laboratory working groups and committees with the aim of harmonizing processes and procedures, ensuring standard quality assurance for protocol-specified assays and laboratory preparedness for network clinical trials.
Save the date for CROI 2023, to be held in Seattle, Washington.
The 2023 Biomedical HIV Prevention Summit is coming to Las Vegas, April 11 – 12. In its seventh year, the Summit focuses on the implementation of biomedical tools in our prevention and treatment efforts to ultimately end the HIV epidemic. The abstract submission deadline is February 6, 2023.
Working together, we can be the generation to end the HIV/AIDS epidemic. Know the facts, spread the word, volunteer for a study, or join a community advisory board.